Standout Papers

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021... 2020 2026 2022 2024399
  1. Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021 (2021)
    Summer E. Galloway, Prabasaj Paul et al. MMWR Morbidity and Mortality Weekly Report
  2. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017 (2020)
    John A. Jernigan, Kelly M Hatfield et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 15 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Global trends in antibiotic consumption during 2016–2023 and future projections through 2030
2024 Standout
2 intermediate papers

Works of Prabasaj Paul being referenced

National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States
2020
Participation in Types of Physical Activities among US Adults—National Health and Nutrition Examination Survey 1999–2006
2015

Author Peers

Author Last Decade Papers Cites
Prabasaj Paul 155 548 299 332 51 1.9k
Mohammad Tahir Yousafzai 38 586 280 319 78 1.7k
Lulla Opatowski 618 669 568 235 74 1.9k
Sarah M. Bartsch 267 533 318 203 55 1.6k
Giovanni Battista Orsi 157 519 326 211 79 2.1k
Timo Smieszek 377 169 586 111 38 1.7k
Stephanie Fletcher 34 446 187 127 45 1.5k
Simon Yung-Chun So 283 640 363 251 73 2.0k
Andrea Piana 43 462 708 141 123 2.2k
Isabel Oliver 227 588 413 123 124 2.3k
Aida Bianco 45 329 732 111 108 2.5k

All Works

Loading papers...

Rankless by CCL
2026